Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
ERK inhib
Welcome,
Profile
Billing
Logout
15 Companies
10 Products
10 Products
27 Diseases
106 Trials
1784 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
10
20
30
40
50
60
70
80
90
100
Zepsun
(donafenib) / Suzhou Zelgen
Rydapt
(midostaurin) / Novartis
dordaviprone
(ONC201) / Chimerix
Triolex
(bezisterim) / BioVie
luxeptinib
(CG-806) / Aptose Biosci
ravoxertinib
(RG7842) / Roche, Pfizer
CC-90003
/ BMS
HMPL-295
/ Hutchmed
HRS2543
/ Jiangsu Hengrui Pharma
KO-947
/ Kura Oncology, Araxes Pharma
VTX-11e
/ Vertex, National Institutes of Health
